The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Open accessAbstract
Nuclear factor-kappa B (NF-kappaB)/Rel transcription factors play an important role in the inducible regulation of a variety of genes involved in the inflammatory and proliferative responses of cells. The present study was designed to elucidate the implication of NF-kappaB/Rel in the pathogenesis of atherosclerosis. Activation of the dimeric NF-kappaB complex is regulated at a posttranslational level and requires the release of the inhibitor protein IkappaB. The newly developed mAb alpha-p65mAb recognizes the IkappaB binding region on the p65 (RelA) DNA binding subunit and therefore selectively reacts with p65 in activated NF-kappaB. Using immunofluorescence and immunohistochemical techniques, activated NF-kappaB was detected in the fibrotic-thickened intima/media and atheromatous areas of the atherosclerotic lesion. Activation of NF-kappaB was identified in smooth muscle cells, macrophages, and endothelial cells. Little or no activated NF-kappaB was detected in vessels lacking atherosclerosis. Electrophoretic mobility shift assays and colocalization of activated NF-kappaB with NF-kappaB target gene expression suggest functional implications for this transcription factor in the atherosclerotic lesion. This study demonstrates the presence of activated NF-kappaB in human atherosclerotic tissue for the first time. Atherosclerosis, characterized by features of chronic inflammation and proliferative processes, may be a paradigm for the involvement of NF-kappaB/Rel in chronic inflammatory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Self-citationRole of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Self-citationEndothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116778 · Cited by 1,072
The inducible transcription activator NF-κB: regulation by distinct protein subunits
Baeuerle, P. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90007-8 · Cited by 1,031
Self-citationIMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Gown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 676
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Libby, P., & Hansson, G. K. (1991) · PubMed · Cited by 663
Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.
Poston, R. N., Haskard, D. O., Coucher, J., Gall, N. P., & Johnson-Tidey, R. R. (1992) · PubMed · Cited by 581
The Structural Biology of Expression and Function of Tissue Factor
Edgington, T. S., Mackman, N., Brand, K., & Ruf, W. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646375 · Cited by 551
Self-citationEndothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
Nuclear factor kappa B, a mediator of lipopolysaccharide effects
Müller, J. M., Ziegler-Heitbrock, H. W. L., & Baeuerle, P. A. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80342-6 · Cited by 475
Self-citationCharacterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).
Iademarco, M. F., McQuillan, J. J., Rosen, G. D., & Dean, D. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42004-2 · Cited by 473
Functional analysis of the human vascular cell adhesion molecule 1 promoter.
Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z., & Collins, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1583 · Cited by 424
Constitutive NF-kB Activity in Neurons
Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., & Baeuerle, P. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3981-3992.1994 · Cited by 394
Self-citationClinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed · Cited by 377
Mackman, N., Brand, K., & Edgington, T. S. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1517 · Cited by 371
Self-citationWeber, C., Erl, W., Pietsch, A., Ströbel, M., Ziegler-Heitbrock, H. W., & Weber, P. C. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1665 · Cited by 340
Markers of mouse macrophage development detected by monoclonal antibodies
Leenen, P. J. M., de Bruijn, M. F. T. R., Voerman, J. S. A., Campbell, P. A., & van Ewijk, W. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90005-1 · Cited by 333
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Duyao, M. P., Buckler, A. J., & Sonenshein, G. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4727 · Cited by 278
Parhami, F., Fang, Z. T., Fogelman, A. M., Andalibi, A., Territo, M. C., & Berliner, J. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116590 · Cited by 257
Levey, A. I., Bolam, J. P., Rye, D. B., Hallanger, A. E., Demuth, R. M., Mesulam, M. M., & Wainer, B. H. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.11.2430010 · Cited by 233
Liao, F., Andalibi, A., Qiao, J. H., Allayee, H., Fogelman, A. M., & Lusis, A. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117409 · Cited by 228
Rosenfeld, M. E., Ylä‐Herttuala, S., Lipton, B. A., Ord, V. A., Witztum, J. L., & Steinberg, D. I. (1992) · PubMed · Cited by 219
Coronary atherosclerosis. A multifactorial disease.
Jj, B., Fuster, V., Chesebro, J. H., & Badimón, L. (1993) · PubMed · Cited by 184
Barath, P., Fishbein, M. C., Cao, J., Berenson, J. R., Helfant, R. H., & Forrester, J. S. (1990) · Europe PMC (PubMed Central) · Cited by 180
Terkeltaub, R., Banka, C. L., Solan, J., Santoro, D., Brand, K., & Curtiss, L. K. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.47 · Cited by 159
Self-citationHamilton, T. A., Ma, G. P., & Chisolm, G. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2343 · Cited by 148
Brand, K., Fowler, B. J., Edgington, T. S., & Mackman, N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4732-4738.1991 · Cited by 146
Self-citationKaltschmidt, C., Kaltschmidt, B., Lannes-Vieira, J., Kreutzberg, G. W., Wekerle, H., Baeuerle, P. A., & Gehrmann, J. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90151-1 · Cited by 142
Self-citationBrand, K., Banka, C. L., Mackman, N., Terkeltaub, R. A., Fan, S. T., & Curtiss, L. K. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.790 · Cited by 121
Self-citationMasuda, J., & Ross, R. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.178 · Cited by 115
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter.
Cheng, Q., Cant, C., Moll, T., Hofer-Warbinek, R., Wagner, E., Birnstiel, M. L., Bach, F. H., & de Martin, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36866-7 · Cited by 105
Selective Recognition of the Activated Form of Transcription Factor NF-χB by a Monoclonal Anfibody
Christian, K., Barbara, K., Thomas, H., Hubert, S., & Baeuerle, P. A. (1995) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1995.376.1.9 · Cited by 94
Self-citationQwarnström, E. E., Ostberg, C. O., Turk, G. L., Richardson, C. A., & Bomsztyk, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47345-0 · Cited by 91
Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.
Brand, K., Mackman, N., & Curtiss, L. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116425 · Cited by 89
Self-citationFong, L., Fong, T., & Cooper, A. D. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41893-0 · Cited by 86
Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell Proliferation
Nakajima, T., Kitajima, I., Shin, H., Takasaki, I., Shigeta, K., Abeyama, K., Yamashita, Y., Tokioka, T., Soejima, Y., & Maruyama, I. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2552 · Cited by 75
Wu, H., Moulton, K., Horvai, A., Parik, S., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2129 · Cited by 46
An Evolutionary and Functional Approach to the TNF Receptor/Ligand Family
Beutler, B., & Huffel, C. V. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44244.x · Cited by 43
Modified Lipoproteins and Atherogenesis
Berliner, J. A., Territo, M., Amdalibi, A., Navab, M., Liao, F., Cushing, S. D., Imes, S., Kim, J., Lenten, B. J. V., Lusis, A. J., et al. (1992) · The Argenteuil symposia · doi:10.1007/978-1-4471-1909-8_7 · Cited by 37
Cited by
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Metadata
- Authors
- Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-04-01
- Volume
- 97
- Issue
- 7
- Pages
- 1715-1722
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2056034929
- Cited by
- 798
- References
- 49
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.